Parameter
| Biomarker | LCN2 | Full name | Serum Lipid Carrier Protein 2 | Molecular Type | protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Inflammation and bone metabolism | ||
| Disease | Osteoporosis (OP) | Disease Subtypes | / | ||
| Organ | Bone, Immune system | Test Sample / Technology Platform | Serum (ELISA, Western blot) | ||
| Pathobiological Mechanisms | Diabetes-associated chronic inflammation induces LCN2 upregulation, which promotes osteoclast differentiation by activating the NF-κB pathway | ||||
| Clinical Availability Status | Research phase | ||||
| Notes and Dynamics | Can serve as an inflammatory biomarker for diabetic osteoporosis | ||||